Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets
VRAX•Supply deal with Fosun Diagnostics
Virax Biolabs entered a commercial supply agreement with Fosun Diagnostics for ImmuneSelect across six Southeast Asian markets.
The deal targets near-term commercial supply and evaluation activity, with an initial focus on tuberculosis-related research applications in Thailand.
Management flagged potential regional expansion through Fosun’s network as it seeks to translate ImmuneSelect demand into revenue.
